An experimental study investigated the effects of calprotectin inhibition in RA using neutralizing monoclonal antibodies in a mouse collagen-induced arthritis (CIA) model, Murine S100A9 monoclonal antibody and anti-TNFα treatment were compared. The gene discussed is S100A9; the disease is rheumatoid arthritis.